Intelligence / Healthtech / New Clinical Trials / Femasys Inc.
Femasys Inc.
9 Nov 2026: Trial registered · A Study to Evaluate the Acceptability of the FemBloc System as a Non-surgical, Permanent Contraceptive Method. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 9 Nov 2026
- Title
- A Study to Evaluate the Acceptability of the FemBloc System as a Non-surgical, Permanent Contraceptive Method
- Conditions
- Contraception
- Study Type
- Observational
- Status
- Active Not Recruiting
- Countries
- Spain
- Country
- Spain
- Reference
- NCT07924293
- Location
- Spain
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Find the decision makers at Femasys Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for Femasys Inc. in our registers.
More from Spain
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.